Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Finished Goods (2024 - 2025)

Historic Finished Goods for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to $1.1 million.

  • Day One Biopharmaceuticals' Finished Goods changed N/A to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $873000.0 for FY2024, which is N/A changed from last year.
  • Day One Biopharmaceuticals' Finished Goods amounted to $1.1 million in Q3 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Finished Goods ranged from a high of $1.4 million in Q2 2025 and a low of $873000.0 during Q4 2024